Cargando…

Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endot...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasarín, Marcos, La Mura, Vincenzo, Gracia-Sancho, Jorge, García-Calderó, Héctor, Rodríguez-Vilarrupla, Aina, García-Pagán, Juan Carlos, Bosch, Jaime, Abraldes, Juan G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317918/
https://www.ncbi.nlm.nih.gov/pubmed/22509248
http://dx.doi.org/10.1371/journal.pone.0032785
_version_ 1782228648352284672
author Pasarín, Marcos
La Mura, Vincenzo
Gracia-Sancho, Jorge
García-Calderó, Héctor
Rodríguez-Vilarrupla, Aina
García-Pagán, Juan Carlos
Bosch, Jaime
Abraldes, Juan G.
author_facet Pasarín, Marcos
La Mura, Vincenzo
Gracia-Sancho, Jorge
García-Calderó, Héctor
Rodríguez-Vilarrupla, Aina
García-Pagán, Juan Carlos
Bosch, Jaime
Abraldes, Juan G.
author_sort Pasarín, Marcos
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endothelial dysfunction within the hepatic vasculature is unknown. The aims of this study were to explore, in a model of diet-induced overweight that expresses most features of the metabolic syndrome, whether early NAFLD is associated with liver endothelial dysfunction. Wistar Kyoto rats were fed a cafeteria diet (CafD; 65% of fat, mostly saturated) or a control diet (CD) for 1 month. CafD rats developed features of the metabolic syndrome (overweight, arterial hypertension, hypertryglyceridemia, hyperglucemia and insulin resistance) and liver steatosis without inflammation or fibrosis. CafD rats had a significantly higher in vivo hepatic vascular resistance than CD. In liver perfusion livers from CafD rats had an increased portal perfusion pressure and decreased endothelium-dependent vasodilation. This was associated with a decreased Akt-dependent eNOS phosphorylation and NOS activity. In summary, we demonstrate in a rat model of the metabolic syndrome that shows features of NAFLD, that liver endothelial dysfunction occurs before the development of fibrosis or inflammation.
format Online
Article
Text
id pubmed-3317918
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33179182012-04-16 Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD Pasarín, Marcos La Mura, Vincenzo Gracia-Sancho, Jorge García-Calderó, Héctor Rodríguez-Vilarrupla, Aina García-Pagán, Juan Carlos Bosch, Jaime Abraldes, Juan G. PLoS One Research Article Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endothelial dysfunction within the hepatic vasculature is unknown. The aims of this study were to explore, in a model of diet-induced overweight that expresses most features of the metabolic syndrome, whether early NAFLD is associated with liver endothelial dysfunction. Wistar Kyoto rats were fed a cafeteria diet (CafD; 65% of fat, mostly saturated) or a control diet (CD) for 1 month. CafD rats developed features of the metabolic syndrome (overweight, arterial hypertension, hypertryglyceridemia, hyperglucemia and insulin resistance) and liver steatosis without inflammation or fibrosis. CafD rats had a significantly higher in vivo hepatic vascular resistance than CD. In liver perfusion livers from CafD rats had an increased portal perfusion pressure and decreased endothelium-dependent vasodilation. This was associated with a decreased Akt-dependent eNOS phosphorylation and NOS activity. In summary, we demonstrate in a rat model of the metabolic syndrome that shows features of NAFLD, that liver endothelial dysfunction occurs before the development of fibrosis or inflammation. Public Library of Science 2012-04-03 /pmc/articles/PMC3317918/ /pubmed/22509248 http://dx.doi.org/10.1371/journal.pone.0032785 Text en Pasarín et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Pasarín, Marcos
La Mura, Vincenzo
Gracia-Sancho, Jorge
García-Calderó, Héctor
Rodríguez-Vilarrupla, Aina
García-Pagán, Juan Carlos
Bosch, Jaime
Abraldes, Juan G.
Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
title Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
title_full Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
title_fullStr Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
title_full_unstemmed Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
title_short Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
title_sort sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of nafld
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317918/
https://www.ncbi.nlm.nih.gov/pubmed/22509248
http://dx.doi.org/10.1371/journal.pone.0032785
work_keys_str_mv AT pasarinmarcos sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld
AT lamuravincenzo sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld
AT graciasanchojorge sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld
AT garciacalderohector sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld
AT rodriguezvilarruplaaina sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld
AT garciapaganjuancarlos sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld
AT boschjaime sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld
AT abraldesjuang sinusoidalendothelialdysfunctionprecedesinflammationandfibrosisinamodelofnafld